Endoscopic Weight Loss Therapy: Clinical Outcomes Over One year of Follow-Up

Summary

The purpose of this study is to better understand the metabolic and hormonal effects of endoscopic bariatric therapy. Specifically, researchers will examine changes in weight, quality of life, and hormonal levels after various endoscopic bariatric therapies. Study procedures include endoscopic interventions (i.e., endoscopic sleeve gastroplasty), blood draw, medical record review, social worker interviews, dietician follow-ups, and clinical follow-up assessments. The study focuses on overweight/obese individuals who will receive an endoscopic bariatric procedure at Cedars-Sinai. The U.S. Food and Drug Administration has approved the EBT procedures as conducted in this study.


Inclusion Criteria

  • Patients who are considering undergoing EBT for weight loss
  • Patients with a BMI >30 kg/m2 (without obesity related comorbidities)
  • Patients with a BMI >27 kg/m2 (with obesity related comorbidities)
  • Patients willing and able to comply with study requirements for follow-up
Show more

Study Location(s)

Beverly

More about this Clinical Trial

Full Title

Endoscopic Weight Loss Therapy: Clinical Outcomes Over One year of Follow-up

Details
Disease Type/Condition

Other

Principal Investigator

Park, Kenneth

Age Group

Adult

Phase

N/A

IRB Number

STUDY00002145

ClinicalTrials.gov ID

NCT05514288

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?

Details
Disease Type/Condition

Other

Principal Investigator

Park, Kenneth

Age Group

Adult

Phase

N/A

IRB Number

STUDY00002145

ClinicalTrials.gov ID

NCT05514288

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?